Ufp Technologies (UFPT) Total Non-Current Liabilities (2010 - 2026)
Ufp Technologies' (UFPT) quarterly Total Non-Current Liabilities came in at $234.0 million in Q1 2026, down 14.32% YoY from $273.2 million in Q1 2025, and up 2.8% on a QoQ basis from $227.7 million in Q4 2025.
Ufp Technologies (UFPT) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Ufp Technologies (UFPT) has 16 years of Total Non-Current Liabilities data on file, last reported at $234.0 million in Q1 2026.
- Quarterly Total Non-Current Liabilities fell 14.32% year-over-year to $234.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $234.0 million (down 14.32% YoY) and the FY2025 annual result came in at $227.7 million, down 17.24% from the prior year.
- Total Non-Current Liabilities rose to $234.0 million in Q1 2026, from $227.7 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $298.4 million in Q3 2024 to a low of $98.8 million in Q1 2024.
- A 5-year average of $182.0 million and a median of $153.1 million in 2022 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 529.29% — and 2023, when it sank 34.44%.
- Tracing UFPT's Total Non-Current Liabilities over 5 years: stood at $131.1 million in 2022, then retreated by 16.12% to $109.9 million in 2023, then jumped by 150.2% to $275.1 million in 2024, then retreated by 17.24% to $227.7 million in 2025, then rose by 2.8% to $234.0 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $234.0 million (Q1 2026), $227.7 million (Q4 2025), and $244.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Ufp Technologies | 2.39 Bn | 2.38 Bn | 50.92 Mn | 217.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 217.78 Mn |
| Mar 31, 2026 | 234.05 Mn |
| Dec 31, 2025 | 227.68 Mn |
| Sep 30, 2025 | 244.63 Mn |
| Jun 30, 2025 | 245.00 Mn |
| Mar 31, 2025 | 273.15 Mn |
| Dec 31, 2024 | 275.09 Mn |
| Sep 30, 2024 | 298.42 Mn |
| Jun 30, 2024 | 102.46 Mn |
| Mar 31, 2024 | 98.84 Mn |
| Dec 31, 2023 | 109.95 Mn |
| Sep 30, 2023 | 112.39 Mn |
| Jun 30, 2023 | 123.12 Mn |
| Mar 31, 2023 | 131.88 Mn |
| Dec 31, 2022 | 131.08 Mn |
| Sep 30, 2022 | 153.08 Mn |
| Jun 30, 2022 | 187.79 Mn |
| Mar 31, 2022 | 144.71 Mn |
| Dec 31, 2021 | 134.50 Mn |
| Sep 30, 2021 | 28.86 Mn |